History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 1, 2010, Pages 22-32

  Andriantsoanirina, Valréie ^a   Ménard, Didier ^a   Tuseo, Luciano ^b   Durand, Rémy ^c  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ; ARTESUNATE; CHLOROQUINE; CHLORPHENOTANE; CYCLOGUANIL; DIHYDROARTEMISININ; FANSIDAR; MEFLOQUINE; PYRIMETHAMINE; QUININE;

DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; GENE; IN VITRO STUDY; INCIDENCE; MADAGASCAR; MALARIA; NONHUMAN; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PREVALENCE; REVIEW; TREATMENT FAILURE; ANIMAL; DRUG EFFECT; DRUG RESISTANCE; HUMAN; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; PARASITOLOGY;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; HUMANS; MADAGASCAR; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 77149174510     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903289670     Document Type: Review

References (67)

1. Willcox ML, Rakotondrazafy E, Andriamanalimanana R, Andrianasolo D, Rasoanaivo P. Decreasing clinical efficacy of chloroquine in Ankazobe, Central Highlands of Madagascar. Trans R Soc Trop Med Hyg 2004;98:311-314
2. Robert V, L e Goff G, Andrianaivolambo L, R andimby FM, Domarle O, Randrianarivelojosia M, et al. Moderate transmission but high prevalence of malaria in Madagascar. Int J Parasitol 2006;36:1273-1281 (Pubitemid 44353483)
3. Romi R, R azaiarimanga MC, R aharimanga R, R akotondraibe EM, Ranaivo LH, Pietra V, et al. Impact of the malaria control campaign (1993-1998) in the highlands of Madagascar: parasitological and entomological data. Am J Trop Med Hyg. 2002;66:2-6.
4. Bernard PM. Trois ans de lutte antipaludique à Madagascar (1950-1951-1952). Bull Madagascar. 1954;96:415-420
5. Joncour G. The fight against malaria in Madagascar. Bull World Health Organ. 1956;15:711-723
6. Blanchy S, R akotonjanabelo A, R anaivoson G, R ajaonarivelo E. Epidémiologie du paludisme sur les hautes terres malgaches depuis 1878. Santé. 1993;3:155-161
7. Lepers JP, D eloron P, Fontenille D, C oulanges P. Reappearance of falciparum malaria in central highland plateaux of Madagascar. Lancet. 1988;1:586.
8. Mouchet J, Laventure S, B lanchy S, Fioramonti R, R akotonjanabelo A, Rabarison P, et al. The reconquest of the Madagascar highlands by malaria. Bull Soc Pathol Exot. 1997;90:162-168
9. Coulanges P, L e Bras J, D eloron P, R amanamirija JA, Biaud JM, Marchais H. In vivo and in vitro study of the chemosensitivity of Plasmodium falciparum in Madagascar, 1982-1986. Arch Inst Pasteur Madagascar. 1987;53:63-76.
10. Ministère de la Santé, du Planning Familial et de la Protection Sociale . Plan stratégique de lutte contre le paludisme, du contrôle vers l'élimination du paludisme à Madagascar. Madagascar : Ministry of Health ; 2007. p. 54.
11. Mouchet J, Carnevale P, C oosemans M, J ulvez J, Manguin S, Richard-Lenoble D, et al. Iles du sud-ouest de l'océan Indien. In: Libbey J, editor. Biodiversité du paludisme dans le monde. Paris : Eurotext; 2004. pp. 167-174
12. Hewitt R, K rause A, G oldman A, C ampbell G, J enkins T. b -Globin haplotype analysis suggests that a major source of Malagasy ancestry is derived from Bantu-speaking negroids. Am J Hum Genet. 1996;58:1303-1308
13. Goasguen J, G entelet B, M oreau J, F ouquet R, C oulanges P. Plasmodium falciparum chloroquino-résistant? A propos des deux premiers cas malgaches. Arch Inst Pasteur Madagascar 1975;44:143-145
14. Aronsson B, B engtsson E, Bjorkman A, P ehrson PO, R ombo L, Wahlgren M. Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann Trop Med Parasitol. 1981;75: 367-373
15. World Health Organization. World malaria report. Geneva: WHO; 2008. Available at: http://malaria.who.int/wmr2008/ MAL2008-CountryProfiles/MAL2008- Madagascar-EN.pdf (accessed September 2009).
16. Barnadas C, T ichit M, Bouchier C, R atsimbasoa A, Randrianasolo L, Raherinjafy R, et al. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulfadoxine-pyrimethamine. Malar J. 2008;7:35.
17. Barnadas C, Ratsimbasoa A, Ranaivosoa H, Ralaizandry D, Raveloariseheno D, Rabekotonorina V, et al. Short report: prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar. Am J Trop Med Hyg. 2007;77:1039-1042
18. Mouchet J, Blanchy S, R akotonjabelo A, R anaivoson G, Rajaonarivelo E, Laventure S, et al. Epidemiological stratifi- cation of malaria in Madagascar. Arch Inst Pasteur Madagascar. 1993;60:50-59
19. Blanchy S, R akotonjanabelo A, R anaivoson G. S urveillance épidémiologique du paludisme instable. Santé. 1993;3:247-255
20. Ménard D, R andrianarivo-Solofoniaina AE, A hmed BS, Jahevitra M, Andriantsoanirina V, Rasolofomanana JR, et al. Drug-resistant malaria parasites introduced into Madagascar from Comoros Islands. Emerg Infect Dis. 2007;13: 1759-1762
21. Razanamparany MS, Randriamiharisoa FA, Razanamparany NJ, Ramialimanana V. The malaria epidemic in Antananarivo from 1983 to 1994 as seen through the Pediatric Service A in the Befelatanana General Hospital. Santé. 1995;5:382-385
22. Razanamparany M, Bosman A, Ravelomanana N, Randriamiharisoa F, Razafimantsoa L. The malaria epidemic in Antananarivo observed from Pediatric Service 'A' of the Befelatanana General Hospital. Parassitologia. 1989;31:89-99.
23. Ratsimbasoa A, R andrianarivelojosia M, M illet P, S oarès JL, Rabarijaona L, Rakotoson B, et al. Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children. Malar J. 2006;5:79.
24. Randrianarivelojosia M, R aharimalala LA, R andrianasolo L, Ratsimbasoa A, Rason MA, Ariey F, et al. Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro. Ann Trop Med Parasitol. 2001;95:237-243
25. Talisuna AO, B loland P, D'Alessandro U. History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev. 2004;17:235-254
26. Deloron P, R amanamirija JA, V erdíer F, C oulanges P. 4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. II. Study in two regions of the east coast. Arch Inst Pasteur Madagascar 1984;51:43-55.
27. Biaud JM, R amanamirija JA, R amiliarisoa O, V erdier F, Coulanges P, Le Bras J. Drug sensitivity of malaria in Madagascar. Comparison in vivo and in vitro of the effects of chloroquine and amodiaquine on Pfalciparum in 1984. Arch Inst Pasteur Madagascar. 1985;52:73-84.
28. Marchais H, R amanamirija JA, L e Bras J, C oulanges P. In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of a study conducted on the east coast (July 1985-July 1986). Arch Inst Pasteur Madagascar. 1987;53:43-62.
29. Coulanges P, Le Bras J, D eloron P, Ramanamirija JA. R esistance of Plasmodium falciparum to 4-aminoquinolines. A review based on the Madagascar experience. Arch Inst Pasteur Madagascar. 1987;53:77-103.
30. Lepers JP, R amanamirija JA, R andriasamimanana JR, R amanandraibe LM, Rahelimalala RS, Rene JP, et al. Malaria in Ile de Sainte Marie in 1988. Epidemiological approach Chloroquine sensitivity of Plasmodium falciparum. Arch Inst Pasteur Madagascar. 1989;56:131-142
31. Lepers JP, Deloron P, Andriamangatiana-Rason MD, Ramanamirija JA, Coulanges P. Sensitivity of Plasmodium falciparum to different antimalarials. A study in 1988 in a village in the Hauts-Plateaux of Madagascar. Bull Soc Pathol Exot. 1989;82:650-657
32. Andriamangatiana-Rason MD, L epers JP, Raharimalala Andrianavalona L, Verdier F, Coulanges P. Aspects of in vivo chemosensitivity of Plasmodium falciparum to chloroquine in a village of the highland plateaux of Madagascar in 1989. Arch Inst Pasteur Madagascar. 1990;57:93-104.
33. Lepers JP, D eloron P, Mouden JC, L e Bras J, C oulanges P. Sudden increase in number of isolates of Plasmodium falciparum resistant to chloroquine in Madagascar. Trans R Soc Trop Med Hyg. 1989;83:491-492
34. Blanchy S, R akotonjanabelo A, R anaivoson G. Evolution of Plasmodium falciparum drug sensitivity in Madagascar from 1982 to 1993 and operational consequences. Bull Soc Pathol Exot. 1993;86:254-259
35. Ringwald P, R abarison P, R aharimalala L, Rason MD, Lepers JP, Le Bras J, et al. Stability and chemosensitivity of Plasmodium falciparum to chloroquine in 1990 and 1991 in Ankazobe, a village in high plateau Madagascar. Bull Soc Pathol Exot. 1992;85:219-222
36. Randrianarivelojosia M, Raharimalala L, R andriamanantena A, Jambou R. Drug resistance of Plasmodium falciparum in coastal regions of Madagascar. Med Trop. 2000; 60:243-249
37. Ménard D, Ratsimbasoa A, Randrianarivelojosia M, Rabarijaona LP, Raharimalala L, Domarle O, et al. Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: updated baseline data from randomized and multi-site clinical trials. Malar J. 2008;7:55.
38. Rakoto SA, R aharimalala L, Jambou R. E tude de la chimiosensibilité de Plasmodium falciparum à Madagascar: 1 - situation des médicaments de seconde ligne à Taolagnaro (quinine, sulfadoxine-pyrimeéthamine). Arch Inst Pasteur Madagascar. 1998;64:51-55
39. Randrianarivelojosia M, Ariey F, R aharimalala LA, P arzy D, Rogier C, Jambou R. Current absence of pyrimethamine resistance of Plasmodium falciparum in Madagascar. Trans R Soc Trop Med Hyg. 2002;96:557-559
40. Randrianasolo L, R andriamanantena A, R atsimbasoa A, Rakotoson JD, Randriambelosoa J, Raveloson A, et al. Surveillance de l'efficacité de sulfadoxine-pyriméthamine (Fansidar® , Paludar® ) pour le traitement de l'accés palustre à Madagascar : proposition d'un protocole simplifié. Arch Inst Pasteur Madagascar. 2003;69:52-56
41. Randrianasolo L, R andriamanantena A, R anarivelo L, Ratsimbasoa A, Domarle O, Randrianarivelojosia M. Monitoring susceptibility to sulfadoxine-pyrimethamine among cases of uncomplicated Plasmodium falciparum malaria in Saharevo, Madagascar. Ann Trop Med Parasitol. 2004;98:551-554
42. Randriamanantena A, Randrianasolo L, V onimpaisomihanta JA, Tafangy PB, Bayant Z, Randrianarivelojosia M. Therapeutic efficacy of amodiaquine against uncomplicated malaria in Madagascar. Santé. 2007;17:75-78
43. Deloron P, Le Bras J, Ramanamirija JA, C oulanges P. Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Ann Trop Med Parasitol. 1985;79: 357-365 (Pubitemid 16250893)
44. Deloron P, L epers JP, V erdier F, Chougnet C, R emanamirija JA, Andriamangatiana-Rason MD, et al. Efficacy of a 3-day oral regimen of a quinine-quinidine-cinchonine association (Quinimax) for treatment of falciparum malaria in Madagascar. Trans R Soc Trop Med Hyg. 1989;83:751-754
45. Rason MA, A ndrianantenaina HB, A riey F, Raveloson A, Domarle O, Randrianarivelojosia M. Prevalent pfmdr1 N86Y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains. Am J Trop Med Hyg. 2007;76:1079-1083
46. Randrianarivelojosia M, R andrianasolo L, R andremanana RV, Randriamanantena A, Ratsimbasoa A, Rakotoson JD. Susceptibility of Plasmodium falciparum to the drugs used to treat severe malaria (quinine) and to prevent malaria (mefloquine, cycloguanil) in Comoros Union and Madagascar. S Afr Med J. 2004;94:47-51.
47. Randrianarivelojosia M, Sahondra-Harisoa JL, Raharimalala LA, Raveloson A, Mauclère P, Ariey F. A network RER rooted on in vitro readout assays of Plasmodium falciparum sensitivity to chloroquine in the Indian Ocean region. Santé. 2003;13:95-100.
48. Randrianarivelojosia M, H arisoa JL, R abarijaona LP, R aharimalala LA, Ranaivo L, Pietra V, et al. In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar. Parassitologia. 2002;44: 141-147
49. Randrianarivelojosia M, R akotonjanabelo LA, M auclère P, Ratsimbasoa A, Raharimalala LA, Ariey F. National network study to perpetuate the surveillance of Plasmodium falciparum sensitivity to antimalarials in Madagascar. Arch Inst Pasteur Madagascar. 2002;68:73-78
50. Randrianarivelojosia M, R atsimbasoa A, R andrianasolo L, Randrianarijaona A, Jambou R. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar. East Afr Med J. 2002;79:237-241
51. Raharimalala AL, R andrianarivelojosia M, Randriamanantena A, Ranarivelo LA, Jaureguiberry S, Rason MA, et al. Chemosensitivity of Plasmodium falciparum in Sainte Marie island, east coast of Madagascar: in vivo and in vitro studies. Arch Inst Pasteur Madagascar. 2000;66:26-31.
52. Rason MA, Ariey F, Rafidimanantsoa L, Andrianantenaina BH, Sahondra Harisoa JL, Randrianarivelojosia M. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests. Parasite. 2002;9:247-253
53. Milijaona R, J ambou R, R aharimalala L, R anaivo L, R ason MA, Roux J. Mefloquine-resistant strains of Plasmodium falciparum in Madagascar: impact on tourists and public health. Ann Trop Med Parasitol. 2000;94:313-317
54. Milijaona R, R aharimalala L, R amambanirina L, R anaivo LH, Jambou R. Drug resistance of Plasmodium falciparum along the borders of the highlands in Madagascar: outlook for a national control program. Med Trop. 1998;58:261-265
55. Lepers JP, R amanamirija JA, R ason MD, Coulanges P. I n vitro sensitivity of Plasmodium falciparum to chloroquine in the highland region of Madagascar in 1987. Bull Soc Pathol Exot. 1988;81:338-344
56. Ramanamirija JA, D eloron P, Biaud JM, L e Bras J, Coulanges P. In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of 2 years' study. Bull Soc Pathol Exot. 1985;78:606-614
57. Deloron P, Ramanamirija JA, Le Bras J, C oulanges P. 4-Aminoquinoline- sensitivity of Plasmodium falciparum in Madagascar III Studies in three regions of the interior. Arch Inst Pasteur Madagascar. 1984;51:57-68.
58. Deloron P, Ramanamirija JA, Le Bras J, V erdier P, C oulanges P. 4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. I. Study in two regions of the west coast. Arch Inst Pasteur Madagascar. 1984;51:29-42.
59. Le Bras J, D ulat C, Coulanges P, R alamboson D, Rakotonirina- Randriambeloma PJ, Deloron P. Preliminary in vitro study of drug sensitivity of Plasmodium falciparum in Madagascar. Arch Inst Pasteur Madagascar. 1982;50:15-22.
60. Raharimalala L, L epers JP, L epers-Rason MD, R abarison P, Ramambanirina L, Roux J. Aspects of Plasmodium falciparum sensitivity to chloroquine in Madagascar from 1982 to 1993. Arch Inst Pasteur Madagascar. 1993;60:60-64
61. Ariey F, F andeur T, D urand R, R andrianarivelojosia M, Jambou R, Legrand E, et al. Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J. 2006;5:34.
62. Ariey F, R andrianarivelojosia M, Duchemin JB, Rakotondramarina D, Ouledi A, Robert V, et al. Mapping of a Plasmodium falciparum pfcrt K76T mutation: a useful strategy for controlling chloroquine resistance in Madagascar. J Infect Dis. 2002;185:710-712
63. Randrianarivelojosia M, Fidock DA, Belmonte O, V alderramos SG, Mercereau-Puijalon O, Ariey F. First evidence of pfcrt mutant Plasmodium falciparum in Madagascar. Trans R Soc Trop Med Hyg. 2006;100:826-830
64. Picot S, O lliaro P, d e Monbrison F, B ienvenu AL, P rice RN, Ringwald P. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria Malar J. 2009;8:89.
65. Ménard D, Andriantsoanirina V, Jahevitra M, Barnadas C, Tichit M, Bouchier C, et al. Dihydrofolate reductase I164L mutation in Plasmodium falciparum, Madagascar. Emerg Infect Dis. 2008;14:1166-1167
66. Hastings IM, K orenromp EL, B loland PB. T he anatomy of a malaria disaster: drug policy choice and mortality in African children. Lancet Infect Dis. 2007;7:739-748
67. Randrianarivelojosia M, Raveloson A, R andriamanantena A, Juliano JJ, Andrianjafy T, Raharimalala LA, et al. Lessons learnt from the six decades of chloroquine use (1945-2005) to control malaria in Madagascar. Trans R Soc Trop Med Hyg. 2009;103:3-10.